Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis
Carla Casulo(University of Rochester Medical Center), Mehdi Hamadani(Medical College of Wisconsin), Sonali M. Smith(University of Chicago), Jonathon B. Cohen(Emory University), Siddhartha Ganguly(University of Kansas Medical Center), Aleksandr Lazaryan(Moffitt Cancer Center), Edward A. Copelan(Levine Cancer Institute), Gunjan L. Shah(Cornell University), Vaishalee P. Kenkre(University of Wisconsin–Madison), Yogesh Jethava(University of Iowa), Hannah Choe(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jonathan W. Friedberg(University of Rochester), Sairah Ahmed(The University of Texas MD Anderson Cancer Center), Hillard M. Lazarus(University Hospitals of Cleveland), César O. Freytes(CHRISTUS Transplant Institute), Andy I. Chen(Scripps Research Institute), Alessandro Digilio, Sachiko Seo(National Cancer Center Hospital East), David A. Rizzieri(Duke University), Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Basem M. William(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Timothy S. Fenske(Medical College of Wisconsin), David J. Inwards(Mayo Clinic), Andrew R. Rezvani(Stanford Blood Center), Sameh Gaballa(Johns Hopkins Hospital), Richard F. Olsson(AstraZeneca (Netherlands)), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Christopher R. Flowers(The University of Texas MD Anderson Cancer Center), Brian K. Link(University of Iowa), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Umar Farooq(Wake Forest University), Rammurti T. Kamble(Baylor College of Medicine), Melham Solh(Northside Hospital), Kwang Woo Ahn(Medical College of Wisconsin), Nina Shah(The University of Texas MD Anderson Cancer Center), Aaron Cumpston(West Virginia University Hospitals)
Cited by 141
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k